Click to view your profile
Click to search for condition or expert
Click to open main menu
Spinocerebellar Ataxia Type 5 Latest Advances
Find the Latest Research About Spinocerebellar Ataxia Type 5
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Treatments
Customize your search results with filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated : 05/19/2022
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
See more filters
Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trial.
Condition:
Spinocerebellar Ataxia Type 2
Journal:
The Lancet. Neurology
Treatment Used:
Riluzole
Number of Patients:
45
Published:
January 22, 2022
View publication
Summary:
Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trial.
Effectiveness of Robotic Exoskeleton-Assisted Gait Training in Spinocerebellar Ataxia: A Case Report.
Condition:
Spinocerebellar Ataxia (SCA)
Journal:
Sensors (Basel, Switzerland)
Treatment Used:
Robotic Exoskeleton-Assisted Gait Training
Number of Patients:
1
Published:
July 24, 2021
View publication
Summary:
Effectiveness of Robotic Exoskeleton-Assisted Gait Training in Spinocerebellar Ataxia: A Case Report.
Current Status of Gene Therapy Research in Polyglutamine Spinocerebellar Ataxias.
Condition:
Polyglutamine Spinocerebellar Ataxias (PolyQ SCAs)
Journal:
International journal of molecular sciences
Treatment Used:
Gene Therapy
Number of Patients:
0
Published:
April 30, 2021
View publication
Summary:
Current Status of Gene Therapy Research in Polyglutamine Spinocerebellar Ataxias.
Docosahexaenoic acid in ARSACS: observations in two patients.
Condition:
Spastic ataxia of Charlevoix-Saguenay
Journal:
BMC neurology
Treatment Used:
Docosahexaenoic acid
Number of Patients:
2
Published:
May 30, 2020
View publication
Summary:
Docosahexaenoic acid in ARSACS: observations in two patients.
Effect of physical rehabilitation in patients with hereditary spinocerebellar ataxia. A systematic review.
Condition:
Hereditary Spinocerebellar Ataxia
Journal:
Rehabilitacion
Treatment Used:
Physical Rehabilitation
Number of Patients:
0
Published:
May 23, 2020
View publication
Summary:
Effect of physical rehabilitation in patients with hereditary spinocerebellar ataxia. A systematic review.
Testosterone Levels Are Decreased and Associated with Disease Duration in Male Spinocerebellar Ataxia Type 2 Patients.
Condition:
Spinocerebellar Ataxia Type 2
Journal:
Cerebellum (London, England)
Treatment Used:
Testosterone Replacement Therapy
Number of Patients:
195
Published:
May 23, 2020
View publication
Summary:
Testosterone Levels Are Decreased and Associated with Disease Duration in Male Spinocerebellar Ataxia Type 2 Patients.
Contributions to the study of spinocerebellar ataxia type 38 (SCA38).
Condition:
Spinocerebellar Ataxia Type 38 (SCA38)
Journal:
Journal of neurology
Treatment Used:
Oral 26-Week Dietary DHA Supplementation, 650 mg/day
Number of Patients:
5
Published:
April 22, 2020
View publication
Summary:
Contributions to the study of spinocerebellar ataxia type 38 (SCA38).
Surgical Responses and Outcomes of Bilateral Medial Rectus Recession in Esotropia With Spinocerebellar Ataxia.
Condition:
Esotropic Patients with Spinocerebellar Ataxia (SCA)
Journal:
Journal of pediatric ophthalmology and strabismus
Treatment Used:
Bilateral Medial Rectus (BMR) Recession
Number of Patients:
15
Published:
July 20, 2019
View publication
Summary:
Surgical Responses and Outcomes of Bilateral Medial Rectus Recession in Esotropia With Spinocerebellar Ataxia.
Neurorehabilitation Improves the Motor Features in Prodromal SCA2: A Randomized, Controlled Trial.
Condition:
Prodromal Spinocerebellar Ataxia Type 2
Journal:
Movement disorders : official journal of the Movement Disorder Society
Treatment Used:
Neurorehabilitation
Number of Patients:
30
Published:
April 09, 2019
View publication
Summary:
Neurorehabilitation Improves the Motor Features in Prodromal SCA2: A Randomized, Controlled Trial.
Inherited Ataxia and Intrathecal Baclofen for the Treatment of Spasticity and Painful Spasms.
Condition:
Inherited Ataxia Spasticity and Painful Spasms
Journal:
Stereotactic and functional neurosurgery
Treatment Used:
Intrathecal Baclofen
Number of Patients:
5
Published:
March 15, 2019
View publication
Summary:
Inherited Ataxia and Intrathecal Baclofen for the Treatment of Spasticity and Painful Spasms.
Speech treatment improves dysarthria in multisystemic ataxia: a rater-blinded, controlled pilot-study in ARSACS.
Condition:
Dysarthria in multisystemic ataxia
Journal:
Journal of neurology
Treatment Used:
Speech treatment
Number of Patients:
0
Published:
March 07, 2019
View publication
Summary:
Speech treatment improves dysarthria in multisystemic ataxia: a rater-blinded, controlled pilot-study in ARSACS.
Effects of Physical Rehabilitation in Patients with Spinocerebellar Ataxia Type 7.
Condition:
Spinocerebellar Ataxia Type 7
Journal:
Cerebellum (London, England)
Treatment Used:
physical rehabilitation
Number of Patients:
18
Published:
February 01, 2019
View publication
Summary:
Effects of Physical Rehabilitation in Patients with Spinocerebellar Ataxia Type 7.
Showing 1-12 of 13
Next
Last Updated : 05/19/2022